193 related articles for article (PubMed ID: 21658622)
1. Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.
Bachy E; Salles G
Best Pract Res Clin Haematol; 2011 Jun; 24(2):257-70. PubMed ID: 21658622
[TBL] [Abstract][Full Text] [Related]
2. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
[TBL] [Abstract][Full Text] [Related]
3. Rituximab maintenance versus retreatment in follicular lymphoma.
Palla AR; Hamadani M
Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic stem cell transplantation in follicular lymphoma.
Khouri IF
Best Pract Res Clin Haematol; 2011 Jun; 24(2):271-7. PubMed ID: 21658623
[TBL] [Abstract][Full Text] [Related]
5. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
[TBL] [Abstract][Full Text] [Related]
6. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation for patients with advanced-stage follicular lymphoma.
Numbenjapon T; Nademanee A
J Med Assoc Thai; 2008 Oct; 91(10):1613-22. PubMed ID: 18972908
[TBL] [Abstract][Full Text] [Related]
8. The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma.
Laport GG
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):59-65. PubMed ID: 16399587
[TBL] [Abstract][Full Text] [Related]
9. Indolent lymphomas: current and emerging treatment approaches.
Maloney D; Kahl BS; Dreyling M
Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma.
Van Besien K
Blood Rev; 2006 Sep; 20(5):235-44. PubMed ID: 16513231
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in autologous stem cell transplantation for follicular lymphoma.
Schmitz N
Anticancer Drugs; 2001 Jun; 12 Suppl 2():S21-4. PubMed ID: 11508933
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategies in follicular lymphomas: current status and future perspectives.
Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Forstpointner R; Nickenig C; Unterhalt M
J Clin Oncol; 2005 Sep; 23(26):6394-9. PubMed ID: 16155025
[TBL] [Abstract][Full Text] [Related]
13. Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphoma.
Hess G; Flohr T; Kolbe K; Bonn S; Schuler M; Derigs HG; Huber C
Ann Hematol; 2006 Nov; 85(11):769-79. PubMed ID: 16896912
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.
Pettengell R
Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153
[TBL] [Abstract][Full Text] [Related]
15. Follicular lymphoma: emerging therapeutic strategies.
Kenkre VP; Kahl BS
Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma.
Berinstein NL; Buckstein R; Imrie K; Spaner D; Mangel J; Tompkins K; Pennell N; Reis M; Pavlin P; Lima A; Couvadia A; Robinson J; Richardson P
Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S14-7. PubMed ID: 11840156
[TBL] [Abstract][Full Text] [Related]
17. Current management of follicular lymphomas.
Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M
Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic advances for indolent lymphomas].
Ogura M
Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategies in advanced stage follicular lymphoma.
van Oers MH; Kersten MJ
Best Pract Res Clin Haematol; 2011 Jun; 24(2):187-201. PubMed ID: 21658618
[TBL] [Abstract][Full Text] [Related]
20. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
